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Environmental Aspects of Injury and
Disease: Liver and Bile Ducts
by Edward S. Reynolds*
Evolutionary processes have not yet developed specific and safe ways to detoxify all chemical species
new to our environment. Indeed, some are transformed and/or conjugated by the liver into more toxic
species. Environmental factors can modulate hepatic enzyme systems. Particularly responsive are the
mixed function oxidases, which initiate the transformation of many xenobiotics to excretable species via
reactions which generate electrophilic intermediates such as free radicals, epoxides and aldehydes. Unless
these reactive metabolites are rapidly removed by subsequent detoxification reactions or by endogenous
defense systems, destructive cytotoxic reactions can be triggered or cell constitutents "attacked" thereby
causing either acute injury and/or more latent molecular injury to long chain biopolymers resulting in
chromatin damage, or tumors.
In vitro systems using purified, specialized cell fractions may be of considerable value in defining
metabolic processes, but the results must be relevant to in vivo conditions. Although human liver is
peculiarly resistant to tumorigenesis, liver microsomes (isolated endoplasmic reticulum) are extensively
used as biological activators for in vitro mutagenicity test systems. The in vivo defense system of liver
cells must be exceptionally efficient! Reactive metabolites generated in liver may be stable enough to
migrate and cause injury to other tissues or organ systems. It is important to characterize metabolic
pathways oftoxic xenobiotics, subsequent molecular sites or modes ofinjury, and factors which depress
or augment cellular defense systems including the biliary system responsible for the excretion of many
xenobiotics. Only then can techniques or treatments be developed to screen individuals for risk tospecific
groups of xenobiotics, to protect those exposed, and to treat those injured.
Introduction
The liver is a metabolically versatile organ re-
sponsible for the regulation ofman's internal chem-
ical environment. Exogenous and endogenous
chemicals are absorbed, concentrated and then
processed by the liver into more "useable," stora-
ble, or excretable forms. Many xenobiotics are
converted at least initially to more excretable
molecular species by components of the relatively
nonspecific, mixed-function oxidases. These and
other hepatic processing systems are responsive to
multiple internal and external factors, such as sex,
age, type of diet, hormone level, and prior or con-
current exposures to foreign chemicals (xenobi-
otics).
Environmental factors can sensitize individuals
to potentially toxic chemicals by altering processes
leading either to their "safe" removal from the
body or their activation into molecular species cap-
able of producing cellular injury. Mechanisms of
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alteration include induction or repression of en-
zymes involved in the metabolic processes, changes
in levels of required cofactors and/or depletion of
antioxidants or other hepatocellular defense sys-
tems. Chemicals activated by the liver may attack
other organ systems. The metabolic capacity ofthe
liver is the central factor in human environmental
response.
Pertinent Organization of Liver
Function
Mammalian liver is a "continuous mass ofparen-
chymal cells tunneled by vessels through which
venous blood flows on its way from the gut to the
heart" (1). Foodstuffs absorbed from the external
environment are processed in the liver for more
specialized, less versatile tissues according to the
body's needs. Dietary changes can be accommo-
dated by shifts in metabolic pathways. Poly- and
oligosaccharides, cleaved by the digestive system,
reach the liver as a mixture of monosaccharides
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for energy or stored as glycogen. A vital function of
the liver is the maintenance ofnormal blood glucose
concentration through the hormone-controlled
build up and breakdown of glycogen and synthesis
of glucose (gluconeogenesis) from 3-carbon precur-
sors. Dietary lipids are processed in the liver to
provide sources of energy or raw material for
synthesis. The liver is particularly important in the
synthesis and regulation of circulating lipids, lipo-
proteins, triglycerides, cholesterol, cholesterol es-
ters and in the degradation of cholesterol and
steroids. Ingested proteins are cleaved to amino
acids prior to absorption and transportation to the
liver, where they are synthesized into structural and
functional proteins for intrinsic and extrinsic use
including plasma proteins, albumin and coagulation
factors. Only the liver contains enzymes capable of
converting nitrogen degradation products into urea
for excretion.
The liver also functions as an endocrine gland in
manufacturing, storing, concentrating and excreting
cholic acid and other bile acids. The biliary system
forms a major pathway for the excretion of conju-
gated xenobiotics. Iron reutilization and the break-
down and excretion of hemeporphyrins also re-
quire participation of the liver. Numerous non-
specific enzyme systems provide the liver with the
flexibility to oxidize, reduce, dehalogenate and/or
conjugate exogenous compounds in order to pro-
duce more excretable compounds, thus maintaining
the hemostatis of the internal environment.
Structure
The massive bulk ofthe liver consists ofmyriads
ofhexagonal prismatic lobules approximately 3 mm
in diameter which are the fundamental units ofliver
function. A branch of the hepatic vein is the center
of each lobule. At the intersection of the interfaces
between lobules are the portal triads which consist
ofsmall branches ofthe portal veins, hepatic artery
and bile ducts, all three ofwhich run concurrently.
Two major types of cells-parenchymal and re-
ticuloendothelial Kupfer cells-populate the lobule.
Parenchymal cells form irregular partitions one cell
thick, lined on both sides by Kupfer cells, whose
attenuated cytoplasm forms the tortuous labyrinth
through which blood percolates on its way from the
portal triad to a branch ofthe hepatic vein.
Kupfer cells form a discontinuous endothelium
with phagocytic properties relatively efficient at
removing particulate foreign matter from the blood.
Their cytoplasm is rich in phagocytic lysosomes.
Parenchymal cells comprise the majority of the
hepatocellular mass and theircytoplasm appears far
more organized than that of Kupfer cells. Structur-
ally, parenchymal cells are dodecahedrons. Paren-
chymal cell surfaces adjacent to vascular spaces
and to the cytoplasmic extensions of Kupfer cells
are microvillus in character, while the surfaces
abutting adjacent parenchymal cells are relatively
smooth. Bile capillaries which transport bile from
the parenchymal cells to the bile ducts in the portal
triads form a network of interfacial canals which
run in the spaces between abutting liver cells.
Functionally the liver cells in the periportal re-
gions (adjacent to a portal triad) differ from those in
the centrolobular region (adjacent to a central vein).
Succinic dehydrogenase, cytochrome oxidase, and
glucose-6-phosphatase are more active in periportal
parenchyma, while NAD- and/or NADP-
dependent lactic, glutamic, and f3-hydroxybutyrate
dehydrogenase and 3,4-benzpyrene hydroxylase
are predominately centrolobular (2). Xenobiotics
have been found more potent inducers of smooth
endoplasmic reticulum in centrolobular than
periportal cells.
Cytoplasm of parenchymal cells contains abun-
dant mitochondria, lysosomes, peroxisomes, Golgi
apparatus, and rough and smooth endoplasmic re-
ticulum, all ofwhich are lined or delimited by phos-
pholipid and protein-rich membranes of differing
composition and function. These appear arrayed in
a highly organized matrix. The plasma membrane
with its many surface specializations forms the
morphologic and functional interface between the
cell and its immediate environment.
The endoplasmic reticulum (ER), a complicated
network of membrane-lined cisternae permeating
the cytoplasmic matrix, is particularly responsive to
environmental changes. Many drugs, such as
phenobarbital, and synthetic chemicals, such as
polychlorinated biphenyls, cause marked prolifera-
tion and alteration of the metabolic properties of
this organelle. The rough (RER) forms broad
sheets, the outer surfaces ofwhich are studded with
myraids of ribosomes in rosettes and spirals. The
other form, the smooth (SER), is a branching, in-
terconnecting, sparsely granulated network of
tubules 50 to 80 nm in diameter. Under normal con-
ditions RER and SER are segregated, flat cisternae
ofthe RER forming many-layered stacks of"ergas-
toplasm" and the SER forming loosely woven
webworks of tubules which permeate the cytoplas-
mic matrix. Protein synthesis takes place on the
ribosomes of the RER, glycogen storage is as-
sociated with the SER, and the entire membrane
system of the ER appears to function in drug and
steroid metabolism.
Fragmented liver endoplasmic reticulum is iso-
lated as a relatively heterogeneous membrane frac-
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experimental molecular biology, pharmacology and
toxicology. Liver microsomes are currently exten-
sively used as biologic activators of chemicals in
mutagenicity in vitro test systems. Oddly, liver is
perculiarly resistant to tumorigenesis, hepatomas
developing in adult human liver only after long-
standing prior cirrhogenic chronic injury. Thus, al-
though components of liver endoplasmic reticulum
are capable of activating chemicals to mutagens in
vitro, the in vivo mutagen defense system of the
liver cells seems exceptionally efficient!
It should be pointed out that liver size (relative to
animal size) is carefully regulated. If portions are
removed surgically or chemically, the liver quickly
returns to normal size through hyperplasia of re-
maining hepatocytes. Causes of increase in size in-
clude conditions which favor storage of glycogen,
fat, or water, and agents which cause proliferation
of endoplasmic reticulum and induction of drug
(xenobiotic) metabolizing enzymes (3).
Cellular Organelles
Different morphologic structures of the liver
parenchymal cell carry out specialized functions.
The nucleus, nucleolus, and polyribosomes are re-
sponsible for the replication of DNA and the trans-
lation of genetic information into RNA, proteins
and other forms of molecular species necessary for
cellular function and replication. Xenobiotics or
their electrophilic metabolites may interact-either
directly or indirectly -at any point in this system.
Mutagens are considered to bind covalently to the
electron-rich centers of DNA bases.
Membranes of the cytoplasmic constituents of
the livercell, endoplasmic reticulum, mitochondria,
peroxisomes, and lysosomes, carry out distinctly
different forms of oxidative metabolism. Substrate
oxidations (and reductions) are also carried out by
the enzymes of the cell sap.
The membranes of the endoplasmic reticulum
hydroxylate endogenous, such as fatty acids and
steroids, and numerous exogenous compounds by a
multimolecular system known as the mixed func-
tion oxidase because one atom ofmolecular oxygen
is reduced to water while the other is incorporated
into substrate (4-6).
RH +2H + 2e-+02 ROH + H20 (1)
In Eq. (1), H+ and e- are derived from either
NADPH or NADH, or both. The versatile mixed
function oxidase systems of liver endoplasmic re-
ticulum carry out numerous reactions including:
nitro reduction, N-dealkylations, O-dealkylations,
S-dealkylations, epoxidations, dechlorinations and
alcohol oxidations. Multiple species of the terminal
oxidase of this system, cytochrome P-450, have
been characterized and demonstrated not only to
have different metabolic capacities but also to be
preferentially inducible (7).
It should be noted that completion of many bio-
transformation processes initiated by components
ofmixed function oxidases of liver endoplasmic re-
ticulum requires participation ofother enzyme sys-
tems. These processes are thus affected by the
availability ofcofactors such as NADPH, NADH,
NAD, 02, reduced glutathione, glucuronate, UTP,
UDP-G, and ATP. Interference with or depletion
of one or more components could impede electron
transport and complex formation or decomposition
causing uncontrolled release of "activated" free
radical or epoxide intermediates to the immediate
intracellular environment. The complexity ofmixed
function oxidase sytems and related conjugation
systems are schematically depicted in Figure 1.
"Safe" transformation of xenobiotics to water-
soluble (oxidized or conjugated) species requires
adequate energy sources, oxygen, and above all
ample endogenous antioxidants to protect cellular
components from the ongoing reactions.
In contrast to the reactions of mixed function ox-
idases [Eq. (1), Fig. 1], electron transport in
mitochondria is tightly coupled to the generation of
high-energy phosphate bonds and terminates in
cytochrome oxidase, which carries out the reduc-
tion of molecular oxygen to water [Eq. (2)].
4e- + 4H+ + 02 - 2H20 (2)
Michaelis (8) postulated that this takes place by a
series of one electron transfers involving free radi-
cal intermediates. Parts of the mitochondrial elec-
tron transport chain are embedded within hydro-
phobic membrane interiors. Mitochrondial mem-
brane integrity appears to be disrupted at an early
stage in the toxic course of some hepatotoxins such
as 1,1-dichloroethylene (Cl2C=CH2) (9).
Peroxisomes carry out the stepwise reduction of
molecular oxygen with the formation of H202 as an
intermediate [Eq. (3)]. H202 may either be broken
down by catalase or peroxidase [Eq. (4)] (10).
2e- + 2H+ + 02
oxidases
H202
(1-a-HO acid oxidases)
H202 + 2e- + 2H+
(3)
(4)
catalase
+ 2H20
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FIGURE 1. A schematization of the nonspecific mixed function oxidase system of the liver endoplasmic reticulum and
related conjugation systems. In the basis reaction (center wheel) substrate (RH) binds to the central hemoprotein
known as cytochrome P-450, is reduced by an electron transferred via flavoprotein (FP) from NADPH and complexes
with molecular oxygen. The complex is then reduced by a second electron derived from NADH (or NADPH). The
triplex of substrate, cytochrome P-450 and 02 decomposes with one atom of oxygen reduced to water and the other
incorporated into the substrate. Oxidized substrates (alcohols, aldehydes, phenols, epoxides) may then undergo con-
jugation reactions with glutathione (lower right), glucuronate (lower left), water, phosphoadenosine phosphosulfate
(PAPS) etc. Modified after Gillette and Jollow (5).
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4Aliphatic alcohols, including ethanol, have also
been postulated by some to be metabolized by this
pathway. Certain hypocholesterolemic compounds
(e.g., ethyl a-p-chlorophenoxyisobutyrate) increase
cellular populations of peroxisomes (11).
Lysosomes, which are more closely associated
with Kupfer cells than parenchymal cells, have
phagocytosis-related NADH oxidase which gen-
erates H202 or other forms ofactive oxygen within
phagolysosomes. In the presence of peroxidases,
H202 generates active halides, superoxide, singlet
oxygen, hydroxyl radical and/or aldehydes, all or
some of which may participate in bacterial killing
reactions and the chemical modification of
phagocytized cellular or extracellular constituents
(12). Contents of lysosomes appear to evolve
through a series of oxidative and polymerization
reactions to relatively inert residual bodies.
Pathologic processes which increase the amounts of
materials being phagocytized causing more rapid
turnover of cellular constitutents in autophago-
somes (e.g., vitamin E deficiency states, copper
toxicity, iron overload) should increase residual
body contents of lysosomes.
Biliary System
Functions of the biliary system (components of
liver parenchymal cells, bile canaliculi, bile ducts,
and gall bladder) include the synthesis of cholic
acids, other bile salts, cholesterol, bilirubin
glucuronides, and their secretion by hepatic paren-
chymal cells. Bile is collected and concentrated in
the gall bladder. Excretion ofthis concentrated bile
is mediated on demand by cholecystokinin. The
biliary system also forms a major pathway for the
excretion of detoxified xenobiotics. Drugs and
chemicals and xenobiotics all may affect the syn-
thesis and/or rates of excretion of components of
bile normally present and affect the stability of this
easily supersaturatable system. Many compounds
excreted in bile are reabsorbed by the intestinal
epithelium only to be re-excreted in the bile (en-
terohepatic circulation).
Klaassen (13), in a recent review (1975), has
summarized research into the biliary excretion of
xenobiotics as follows: 'The biliary route is very
important for the elimination of some foreign com-
pounds from the body. For many of these com-
pounds, an increase in the rate at which they are
excreted into the bile will decrease their toxicity
and vice versa. A number of factors which are
known to alter the biliary excretion ofxenobiotics,
as well as the current concepts of the physiological
mechanisms responsible for the excretion offoreign
compounds, have been enumerated. However,
much remains still to be understood; essentially
nothing is known at the subcellular level about the
biliary excretion of foreign compounds. It has re-
cently been concluded that our knowledge ofbiliary
excretion of compounds is about 40 years behind
that of the renal excretion mechanism."
Mechanisms of Hepatic Injury
by Environmental Chemicals
One of the liver's activities is the processing of
chemicals derived from the environment. Modern
man is literally deluged with molecular species un-
known even fifty years ago. Evolutionary processes
have not yet developed specific and safe pathways
to process and excrete all species of this deluge
from our synthetic era. Appendix I lists the most
extensively produced compounds which are dem-
onstrated or potential hepatotoxins. Appendix II
lists types of occupational and environmental ex-
posure to these hepatotoxins. Entry of certain of
these foreign species into our internal environment
can cause interference with hepatic processes by
depletion of cofactors or through "accidental" in-
sertion into complex molecules during synthesis.
For example, ethionine interferes acutely with cel-
lular function, protein synthesis and nuclear and
polyribosomal structure by sequestering adenine
thereby producing a conditioned deficiency of the
ATP necessary for DNA, RNA, and protein
synthesis (14). Mercury and arsenic combine with
sulfhydryl enzymes and thus impair hepatic
metabolic functions.
Another perhaps more serious danger is that
xenobiotics will be activated by the relatively indis-
criminate" enzyme system into reactive elec-
trophilic molecular species capable of "attacking"
cellular constituents, or initiating destructive pro-
cesses such as lipid peroxidation. The liver mixed-
function oxidase system is thought to activate many
xenobiotics including haloalkanes and haloalkenes
(carbon tetrachloride, halothane, vinyl chloride,
trichloroethylene) (15), haloaromatics (hexa-
chlorobenzene, bromobenzene, lindane, DDT) and
carcinogens (3,4 benzpyrene, 2-acetylaminofluo-
rene, aflatoxin B) (16), and dimethyl or
diethylnitrosomine (17). Appendix III provides ex-
amples of mechanisms by which these toxins are
activated.
Recent biologic studies ofthe industrially impor-
tant compound vinyl chloride (ClHC=CH2) illus-
trate how many factors can be involved in xenobi-
otic activation. Exposure to vinyl chloride under
occupational conditions (long-term, low-dose) has
been associated with nonmalignant liver injury and
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mental animals (18, 19). A single 6-hr exposure to
5% vinyl chloride causes acute injury to liver endo-
plasmic reticulum in animals pretreated with potent
inducers ofcytochrome P-450, the terminal oxidase
of the liver mixed function oxidase system (9).
Diminution ofliver cytochrome P-450 contents and
some functional activities ofthe mixed function ox-
idase system of animals by one day after vinyl
chloride exposure implies that the activated vinyl
chloride species either directly "attacks" mem-
brane constituents or initiates reactions leading to
their destruction (20). In vitro studies of vinyl
chloride have shown that the vinyl chloride
molecule can covalently bind to proteins and nu-
cleic acids or cause mutagenesis oftest bacteria sys-
tems when activated by a microsomal enzyme sys-
tem containing the required cofactors (21). In-
hibition of cytochrome P-450 markedly reduces the
binding of vinyl chloride to proteins (21).
The complexity of pathways by which vinyl
chloride and other heptotoxins such as halogenated
aromatics can be activated to electrophilic species
and subsequently deactivated is suggested by Fig-
ure 2. Such schemes may provide insight into the
complexity of the multienzyme interactions and
how easily they may be thrown out ofbalance. For
example, bromobenzene is activated by the mixed-
function oxidase system to an epoxide which then
rearranges to a phenol or is converted enzymati-
cally either to a dihydrodiol or to a glutathione con-
jugate. When the rate of glutathione depletion ex-
ceeds the rate of glutathione synthesis, bromoben-
zene epoxide covalently binds to proteins of the
intracellular environment-presumably directly
causing injury. Impaired synthesis of reduced
glutathione could enhance bromobenzene' s
cytotoxic effect, while induction of the dihydrodiol
pathway or alternate pathways of bromobenzene
metabolism could minimize its toxic effect (4). Ac-
tions of other factors which perturb the membrane
system in which the xenobiotic-metabolizing en-
zyme systems (see Fig. 1) are embedded or at-
tached could disturb the intermolecular relation-
ships between the various components causing pro-
found imbalances in the detoxification pathways.
Which metabolite is carcinogenic? Which acutely
hepatotoxic? What are the structural parameters of
xenobiotics which allow prediction of cytotoxicity
and/or of carcinogenicity? What parameters of
xenobiotic metabolites determine stability and
selective chemical reactivity, i.e., which elec-
trophilic metabolites are sufficiently stable to mi-
grate from endoplasmic reticulum to nuclei where
they selectively and covalently bind to electron-rich
groups of DNA bases? Indeed, how are these car-
cinogenic electrophiles which may be generated in
liver exported to nuclei of other cellular species of
liver, to nuclei of cells of other organs, or across
placentas to developing fetuses? All these parame-
ters are but poorly understood, indeed, are poorly
substantiated in vivo!
Definition of a Person at Risk in
the Environment with Regard to
Liver Injury
Species, sex, age, diet, habits, genetic differ-
ences, prior environmental or occupational expos-
ure, neonatal exposure to compounds with hor-
monal activity, and other factors yet unknown
modulate the responses of individuals to chemical
agents in their environments.
Some differences are obvious. Rats, whales, and
deer do not have gall bladders. Thus they do not
have gall stones. Male rats metabolize drugs more
rapidly than fema,les. Other differences are more
subtle, such as exposure to aromatic wood prod-
ucts, polycyclic hydrocarbons in tobacco smoke,
and consumption of charcoal broiled meats, rancid
(peroxidized) fats, or food products containing
xenobiotics with estrogenic activities.
Since many potentially injurious environmental
agents produce their effects through interaction
with the mixed function oxidases ofliver endoplas-
mic reticulum, the ability of this enzyme system to
activate them to proximate toxins, or to subse-
quently deactivate them is significant. Fetal and
newborn rats have very lowcontents ofcytochrome
P-450 and other drug metabolizing components, as
well as the enzymes of the glucuronide and
glutathione conjugating systems (6). These en-
zymes rapidly develop aboutthe time ofbirth. Fetal
and neonatal primates including man appear to have
mixed function oxidase activities that are higher
than rats, approaching 20 to 40%o of the levels in
adults. Since components ofthe mixed function ox-
idase system not only activate (toxify) xenobiotics
but also detoxify the activated metabolites, imbal-
ances may occur in such a system, particularly
when specific components are present in different
amounts at different developmental stages, or are
selectively induced or destroyed by the xenobiotics
themselves. Depending upon the developmental
stage, production of electrophilic xenobiotic
metabolites may greatly exceed or be balanced by
the ability to safely detoxify them. Since mixed
function oxidases are responsive to multiple inter-
nal and external factors, conditions at certain times
may favor pathways which produce relatively sta-
ble xenobiotic electrophiles. If these electrophilic
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FIGURE 2. Simplified kinetic flow diagram of xenobiotic toxification-detoxification. Xenobiotics may be metabolized by
more than one pathway (k1 or k2) which may be differentially inducible. The assumption is made that the epoxide
product of k, is a cytotoxic or mutagenic electrophile capable of interaction with vital cellular components (k7).
Hydration (k3), conjugation (k, k5), and rearrangement (k6) transform the epoxide intermediate, presumably to less
toxic compounds. However, compounds formed subsequently, such aldehydes may also be toxic (k1l). Induction of
alternate pathways ofinitial metabolism (k2) may diminish epoxide formation and induction ofk3, k,, or k5 may shorten
its existence. Depletion of conjugation cofactors (glutathione, glucuronide) would minimize detoxification pathways
(k, k5) and allow increased covalent binding (k7, k,,) to occur. Modified after Gillette and Jollow (5) and Robinson et al.
(6).
metabolites migrate to the cell nuclei, to nuclei of
other liver cells, or indeed are exported to nuclei of
cells of other organs, their covalent binding to
DNA may result in tumors. If such events occur
during the early weeks of gestation, developmental
defects or teratogenic effects may ensue or the
molecular seeds may be sown in the fetus for the
subsequent development of a tumor. Cytotoxic tis-
sue injury due to metabolism of xenobiotics by the
mixed function oxidase system usually require rela-
tively extensive or intensive exposure, whereas
mutagenesis may occur with low dose exposure, if
stable electrophiles ensue.
What is the evidence that such events do occur?
Covalent binding in lipids and proteins has been
correlated with cytotoxic tissue injury (22, 23).
Oesch (24) found that induction ofarylhydrocarbon
monooxygenase in fetal rat liver is not accompanied
by induction of an epoxide hydrase, one of the de-
toxifying enzyme systems, and that microsomes of
ratfetuses transplacentally exposed to benzopyrene
provided a more potent activation system in
mutagenic assays ofbenzpyrene to S Typhimurium
TA 1573 than microsomes from fetuses of control
rats not exposed to benzpyrene transplacentally.
Robinson et al. (6) demonstrated genetic differ-
ences in the inducibility of arylhydrocarbon
monooxygenase in liver (determined by the Ah
locus) in mice and in man and the placental induc-
tion of arylhydrocarbon hydroxylase in smoking
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7mothers. Furthermore, in mice, responsiveness at
the Ah allele is a predictor of protection against
hepatocellular injury following lindane or
bromobenzene. Deficiency in a potential detoxifi-
cation pathway, such as the glucuronide conjugat-
ing enzyme system, i.e., Gilbert's Disease, may
represent but one of many of the types of
deficiencies-genetic or otherwise-that may de-
velop. Slow acetylators ofisoniazid may be another
group. People such as these may be among those
who have untoward reactions towards xenobiotics
in the environment. Ways to detect these persons
potentially at risk must be developed.
Types of Injury Related
to Environmental Exposure
Developmental defects, hepatomas, acute
hepatocellular necrosis, chronic persistent
hepatitis, post-necrotic scarring, micronodular cir-
rhosis associated with alcoholism, biliary cirrhosis,
gall stones all may result from environmental ex-
posure to xenobiotics. Unfortunately we do not yet
know how, in these instances, to make a definitive
diagnosis ofchemical etiology. Only when the time
between exposure to a specific compound and in-
jury is brief or chronic (such as occupational) are
we able to make a presumptive diagnosis ofchemi-
cal etiology. Development of jaundice following
exposure to a compound is usually taken as pre-
sumptive evidence for cause and effect, particularly
if the compound is also an acute (or chronic)
hepatotoxin in experimental animals. In the case of
carbon tetrachloride, perhaps the most intensively
studied hepatoxin, we still do not know what dis-
tinctive morphologic or chemical changes to seek to
make a definitive diagnosis of carbon tetrachloride
poisoning, i.e., those changes which differentiate it
from injury following exposure to other acute
hepatotoxins.
Halothane has been suspected of being an acute
hepatotoxin in man since its introduction as an
anesthetic. Also, continued exposure to low con-
centrations has been associated with increased in-
cidence of spontaneous abortions and congenital
defects in operating room personnel (25). Yet a
nation-wide inquiry into the possible relationships
between halothane anesthesia and postoperative
jaundice (National Halothane Study, 1969) did not
find morphologic patterns of acute liver injury that
were distinctive for injury caused by halothane.
Halothane has recently been shown to be an acute
hepatotoxin in polychlorinated biphenyl-pretreated
rats (26, 27), and under similar circumstances of
mixed-function oxidase induction it may be directly
hepatotoxic in man. Definitive diagnosis awaits
chemical definition of the lesion, including detec-
tion and determination of injury-associated
halothane metabolites in breath, blood, and urine.
Chronic liver injury in vinyl chloride workers is
manifest by a rather nonspecific periportal fibrosis
which in the most advanced instances may resem-
ble primary biliary cirrhosis (18). Vinyl chloride-
induced angiosarcoma develops in those chroni-
cally injured livers. It is assumed that metabolites
of vinyl chloride cause both the chronic injury and
the angiosarcoma.
Ethanol is a classic case. It is still not known how
this ubiquitous compound consumed in billions of
pounds yearly produces its devastating effect on the
liver.
Clearly, more effort needs to be expended in
these areas. Injury producing pathways of xenobi-
otic metabolites need to be delineated, the metabo-
lites sought and the products of their interaction
with cellular constitutents determined. Chemical,
functional, and morphologic correlates should be
sought to provide better basis for the recognition of
the causes of similar lesions in the future. Unfortu-
nately for the diagnostician, the early hepatic injury
caused by CC14, halothane, vinyl chloride, or
trichloroethylene exposure all resemble one
another morphologically with formation of tubular
tangles of smooth endoplasmic reticulum and func-
tionally with deactivation ofcytochrome P-450 and
mixed function oxidase components. Yet the first
two haloalkanes are presumed to act through free
radical mechanisms and the secondtwo haloalkenes
through epoxide intermediates (15). Characteriza-
tion of molecular changes in the membrane may
provide a definitive answer. Fortunately, once you
know what to look for, it is easy to identify.
Detection of Injury-Producing
Potential
Quantitative predictors of the toxin-generating
reactivity of chemicals in biological systems are
needed. Physical chemical parameters ofmolecular
structure related to the ability to produce overt in-
jury or more subtle changes in hepatic function
need to be defined and structure-activity guidelines
developed. However the development of such
guidelines requires the development of methods to
isolate and quantify metabolites ofxenobiotics, and
to detect, define and quantitate the magnitude of
injury. Noninvasive methods to determine xenobi-
otic body burden, and rates and routes of xenobi-
otic metabolism should be developed utilizing
breath, blood, urine, and bile, particularly in in-
stances where there is the possibility of a relation-
ship between xenobiotic exposure leading to overt
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In order to know what metabolite to seek, rela-
tionships between xenobiotic metabolism and in-
jury must be sought in experimental animals
-preferably whole animals. Studies with isolated
organs, cell suspensions, parts of cells and soluble
extracts may not relate readily to conditions in vivo.
Only in vitro systems which resemble defined in
vivo systems are valid. Choice of animal is impor-
tant for results must ultimately relate to disease in
man and screening for injury-related metabolites
should be applicable to man.
Clearly, there is a need for more definitive and
more sensitive detection of hepatic injury in man
exposed to the modern world ofchemicals. Current
methods are acceptable for symptomatic acute or
chronic liver disease but usually fail to indicate on-
going subclinical or occult liver disease. Changes in
liver-derived serum enzyme activities should con-
tinue to be explored in a search for more sensitive
indicators. Rates of liver synthesis or removal of
serum lipids, proteins, lipoproteins, corticosteroids
and sex hormones might provide some insight into
functional defects brought about by xenobiotic ex-
posure. Serum determinants ofthe status ofthe an-
tioxidant defense of the liver (reduced/oxidized
glutathione, vitamin E oxidation products) could re-
late to increased intracellular peroxide generation.
Increased mercapturic acid excretion in urine could
relate to increased xenobiotic detoxification. To de-
termine the status of mixed function oxidases in
people who might be at high risk ofliver injury be-
cause of exposure to certain xenobiotics, noninva-
sive tests of the metabolic capabilities ofthe mixed
function oxidases should be developed.
Similarly, better morphologic and cytochemical
parameters ofthe types and extents ofinjury to the
liver need to be developed. Because the liver is
such a heterogeneous organ with segregation of
function and toxic response by zone and cell type,
histologic, histochemical, and physical techniques
are particularly valid. Large changes in the function
or composition of small numbers of cells may be-
come indiscernible when averaged out over the
total population as would occur following
homogenization of the liver.
Certain hepatotoxins produce striking ultrastruc-
tural changes in liver parenchymal cells. Although
several different general classes of injury can be
recognized by electron microscopy-mitochondrial
swelling and/or calcification, dilitation ofrough en-
doplasmic reticulum, "denaturation" of the
smooth, production of "finger print" whorls of the
smooth, segregation of nucleolar and nuclear com-
ponents, increased cytoplasmic contents of peroxi-
somes or autophagosomes-for the most part, the
molecular causes of these changes are not known.
Ultrastructural studies could localize the initial site
ofhepatocellular change, however it should be rec-
ognized that structural alterations results from
rather complex molecular changes, the basis of
which is poorly understood. If the chemical causes
were known, it would render the ultrastructural
studies more definitive and thus, more useful as
screening procedures.
New and Novel Approaches
Increasing awareness that xenobiotic-induced
cellular injury results from finite chemical changes
in the constituents of the cell, and that elucidation
of the injury-producing mechanism depends upon
the detection of these molecular changes em-
phasizes the need for new and better techniques to
analyze and to reproduce the injury in more uniform
populations ofcells. One must always keep in mind,
however, that the lesion produced in vitro must al-
ways replicate that produced in vivo.
Suspensions ofparenchymal cells, or reticuloen-
dothelial cells, either from dissociated livers or cell
cultures might be used to test injury producing
potential(s) of chemical agents. Kinetics would be
simpler and different parameters of injury might be
selectively enhanced or suppressed. Cellular sus-
pension of dissociated hepatocytes can be further
separated into large and small hepatocytes (as-
sumed centrolobular and periportal, respectively)
with differing metabolic functions. Fractionated or-
ganelles would then also be more homogeneous.
Clearly, the screening potential of such super-
specialized systems, for example in mutagenesis as-
says, need to be examined.
Only by understanding the molecular basis of in-
jury can we learn what to look for to detect early
injury and to provide methods for its prevention or
reversal. Prediction of injury producing potential
depends upon information which still needs to be
gathered.
Recommendations
RECOMMENDATION 1: Since most xenobiotics
present in the environment interact with con-
stituents ofliver and cause alterations and/or injury
to that organ and possibly others through their
metabolites, metabolic pathways of xenobiotics
need to be better understood and the types of
metabolites associated with injury classified.
RECOMMENDATION 2: Although the association
between xenobiotic toxic action and metabolism
must be worked out in the experimental animal,
metabolite production and associated liver injury
October 1977 9must be sought in persons exposed to such com-
pounds in their environment. Detection of injury-
associated compounds in serum, breath, or urine of
persons could be used to estimate extent of expo-
sure and risk.
RECOMMENDATION 3: Simple test systems
using perfused livers, suspended hepatocytes ob-
tained from enzymatically disassociated livers,
hepatocytes inculture, ororganelle fractions should
be developed for screening of metabolic pathways
ofxenobiotics metabolism and detection ofthe pro-
duction of potentially injurious metabolites.
RECOMMENDATION 4: Since the actual molecu-
lar mechanisms responsible for hepatocellular in-
jury by chemical agents are poorly understood,
ways to better define the molecular events involved
in hepatocellular injury by specific chemical agents
and to characterize and quantify injury should be
developed.
RECOMMENDATION 5: Better noninvasive or
minimally invasive methods to detect alterations of
liver structure and function should be developed
and applied to people who may be at risk because of
their environment but who are not overtly ill.
RECOMMENDATION 6: More rational definitions
of risk and of conditions which enhance or protect
against injury must be made on the basis of direct
and not inferred evidence.
Appendix I
Compounds of Significance in the Environ-
ment by Quantity ofProduction (Top 100 in
1970) Which are Potential or Demonstrated
Hepatotoxins, Cohepatotoxins, or Inducers
of Hepatotoxicity
A. Hepatotoxins, demonstrated:
Vinyl chloride
Carbon tetrachloride
Carbon disulfide
Perchloroethylene
Trichloroethylene
1 1,I -Trichloroethane
Chloroform
Chlorobenzene
Methylene chloride
Dichlorobenzene
B. Hepatotoxins, potential:
1,2-Dichloroethane
1,2-Dibromoethane
Styrene
Ethylene oxide
Acetaldehyde
C. Cohepatotoxins (compounds without demon-
strated primary hepatotoxin potential which
potentiate hepatotoxicity of other chemical
hepatotoxins) (Term reserved for compounds
which do not or have not been demonstrated to
modulate the mixed function oxidases).
Isopropyl alcohol
Acetone
n-Butyl alcohol
Ethyl alcohol
D. MFOS inducers, not necessarily cytotoxic in
themselves but which distort the physiologic re-
sponsiveness of the animal
DDT
Benzene
Xylene
Toluene
Polychlorinated biphenyls (chlordane and
other halogenated or chlorinated pesticides,
herbicides)
E. Other industrial, agricultural, pharmaceutical
and natural chemicals ofdemonstrated or poten-
tial hepatotoxic occupational or environmental
risk
Vinyl bromide
Vinylidine chloride
Vinylidine bromide
lodoform
Methylmercury
Halothane
Manganese
Arsenic
Thorium
Chromium
Cadmium
Antimony
Mercury
Yellow phosphorus
Selenium, tellurium
Flame retardants
Ethylene-chlorohydrin
Appendix 11
Examples of Types of Occupational and En-
vironmental Exposure to Potential
Hepatotoxins
1. Food production
Pesticides
Herbicides
Fumigants
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Preservatives
Dyes
Solvents
Packaging
3. Manufacturing
Plastic monomers
Petrochemicals
Synthetic fabrics
Industrial degreasers
Metal and electrical equipment
Fabrics
Forest products
4. Service
Vehicle supply and maintenance:
(degreasers, refrigerants, solvents)
Dry cleaning solvents for degreasing
Janitorial solvents for dewaxing, carpet clean-
ing, window washing
Medical:
Anesthetic gases
Solvents for tissue processing and chemical
analysis
Personal care
Beauticians
Cosmetologists
Barbers
5. Housekeeping
Cleaning aids, solvents, and waxes
Grooming aids
Propellants
Solvents
Emulsifiers
Paints, varnishes
Foodstuffs, including packaging
Appendix III
Example of Known or Postulated
Chemical Mechanism of Toxin
Activation and Detection of Toxin-Related
Injury (Toxigenic Reactions)
Free-Radical Reactions: Free radical reactions
are postulated to take place as a consequence of
single-electron capture reactions by xenobiotic
molecules and their subsequent dissociation into
xenobiotic free radicals and anions. The most likely
source of such electrons is considered to be the
electron transport chain of the mixed function ox-
idases of liver endoplasmic reticulum, although
similar reactions may be initiated by the mitochon-
drial electron transport chain, and through interac-
tion with peroxides in peroxisomes and phagolyso-
somes.
Carbon tetrachloride is thought to be the best ex-
ample ofa "free-radical" toxin. Its initial homolytic
cleavage is considered to occur as shown in Eq.
(A-1).
CC14+ e- - CC13 + Cl- (A-1)
The CCI3 radical then either abstracts labile hy-
drogens with the formation of CHC13 or covalently
binds to electron-rich areas of proteins and lipids.
In both instances, protein and lipid free radicals are
produced which react subsequently in free-radical
propagation or diradical annihilation reactions, re-
sulting in lipid peroxidation or molecular polymeri-
zation.
Direct evidence for the free radical metabolism of
CCI., includes the formation ofCHC13 (the result of
abstracting labile hydrogens), C2C16 (the diradical
annihilation product), and the presence ofincreased
conjugated diene content in lipids (a consequence of
scouring of labile hydrogens from methylene
bridges ofpolyunsaturated fatty acids). Preferential
covalent binding to lipids is suggestive, but the
chemical sites of covalent binding have not been
characterized.
Epoxide Formation: Xenobiotics are con-
verted into epoxides by components ofmixed func-
tion oxidase as shown in Eqs. (A-2) and (A-3).
0
R-C=C-R' -p- R-C-C-R' (A-2)
(A-3) Br
Both alkenes and arenes may be metabolized. Their
intermediates may either rearrange spontaneously
to less toxic compounds, conjugate with H20, re-
duced glutathione, or bind covalently to elec-
trophilic groups in tissue macromolecules. Cytotox-
icity is considered to be related to the magnitude of
covalent binding. Carcinogenic intermediates of
benzanthracenes are also considered to be epoxides
(specifically the 9-10 epoxide).
Evidence of epoxide formation of alkenes is
the formation of trichloroethanol from tri-
chloroethylene, a process involving chloride shift
under the influence of an active oxygen at cyto-
chrome P-450. The shift ofhydrogen between the 3
and 4 position in the formation of p-bromophenol
from bromobenzene (the NIH shift also supports
initial metabolism via formation of an epoxide in-
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thracenes have also been isolated. However, forthe
most part, unless the epoxide is remarkably stable,
the existence of the epoxide is deduced from the
analysis of its more stable products. Specific
cytotoxicity-related covalent binding targets in tis-
sue macromolecules have not been elucidated.
Aldehydes: Aldehydes are generated by al-
cohol dehydrogenases in the cytoplasmic matrix,
through metabolism of xenobiotics by mixed func-
tion oxidases, and through the activities ofcatalase
or peroxidase in peroxisomes. Allyl alcohol, which
produces a severecoagulative necrosis ofperiportal
hepatocytes, is considered to be converted to the
presumptive noxious agent allyl aldehyde (acrolein)
by alcohol dehydrogenases [Eq. (A-4)].
N (S) Oxidation: The liver carcinogen
2-acetylaminofluorene is N-hydroxylated by either
cytochrome P-450 related enzymes or amine-
N-oxidase [Eq. (A-7)]. The hydroxyl amine group
may then form a sulfate ester.
oo~~K ,C-CH3
0
C-CH3
INOH
0
NAD / H2C=CH-CH20H -)- H2C=CH-C
H
(A-4)
Aldehydes are then presumed to form Schiff's
bases with primary amines, redox condensation
products with peptide bonds, alcohols, thiols, etc.
Epoxides of unsaturated haloaliphatics such as
those formed from trichloroethylene by the mixed
function oxidases may rearrange non enzymatically
to form aldehydes which then react with their chem-
ical environment. Products such as these which
might be related to injury have not been verified.
Oxidative X Dealkylation (X = N,S,O):
Compounds such as the diallyl nitrosamines are
N-demethylated by cytochrome P-450 associated
enzymes to monoalkylnitrosamines, whichi spon-
taneously rearrange to unknown active metabolites
which may include electrophilic alkyl carbonium
ions.
CH3
CR N-N=O - CH3-NHN=O + CH20 (A-5)
CH3-NHN=O - CH3+ (A-6)
Dimethyl nitrosamine is acutely cytotoxic at high
doses and a carcinogen at low doses. Not only is it
an hepatocarcinogen, but it will also induce tumors
in other organs-the electrophilic alkyl radicals
which have been preferentially recovered co-
valently bound to amino groups of purine and
pyrimidine bases of DNA are considered by most
to be the carcinogenic vector. The molecular basis
of its cytotoxic action is not understood, but it
should be noted that the leaving methyl group in
reaction (A-5) is oxidized to formaldehyde.
O=S-O-
11
(A-7)
Both the N-hydroxyl and the N-hydroxyl sulfate
ester bind to nucleophilic centers in bases of liver
DNA in vivo.
Cofactor Depletion: The complexity of struc-
ture and of metabolic processes in liver cells em-
phasizes the importance of the distribution and
concentration of cofactors and their precursors in
the regulation ofnormal cell function and responses
of cells to injury. Indeed, certain xenobiotics have
profound effects on cofactor levels. Ethanol in-
creases liver contents of NADH and NADPH.
Ethionine through the formation of S-adenosyl
ethionine depletes the liver ofadenine nucleotides,
thus bringing nucleic acid and protein synthesis to a
halt. Component of nucleoli segregate but cells do
not die. This affect is apparently unrelated to its
ability to produce tumors.
Similarly, galactosamine through the formation of
uridine diphosphogalactosamine depletes the liver
cell of uridine phosphates and uridine sugars and
brings RNA and protein synthesis and glycosyla-
tion reactions to a halt. Large doses produce ne-
crosis, not because they interfere with protein syn-
thesis, but because increased plasma membrane
permeability to calcium develops. Thus xenobiotic
impairment ofcell coat renewal processes may have
lethal consequences.
Diethyl maleate depletes liver of reduced
glutathione but does not produce necrosis.
Bromobenzene depletes cells of glutathione and
produces necrosis. Bromobenzene is metabolized
to potent electrophiles, which in the absence of
glutathione covalently bind to liver macro-
molecules; yet bromobenzene-induced hepatic in-
jury is not manifest until hours after the depletion of
glutathione.
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12Hepatic Porphyria: Certain xenobiotics
grossly disturb the synthesis ofporphyrins in livers
of experimental animals. Similar mechanisms may
be operative in man. Since the rate of synthesis is
controlled by intracellular free (?) heme levels, de-
creases in heme brought about through the destruc-
tion of heme [2 allyl-2-isopropylacetamide (AIA)],
inhibition of ferrochelatase which inserts iron into
the porphyrins /3,5-diethyoxy carbonyl-1,4-dihy-
drocolkdene and increased synthesis of hemopro-
teins (perhaps coupled with increased destruction
of hemoproteins) (hexachlorobenzene?), greatly
stimulate 8-aminolevulinic acid synthetase and
porphyrin production, presulting in porphyria.
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